Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Semi Synthetic Taxane Modification. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101353333B details a novel synthesis route for paclitaxel analogues offering high yield and reduced multidrug resistance for reliable pharmaceutical intermediate supply chains.
Patent CN106167474A details a high-yield Azitaxel synthesis using 10-DAB, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.